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Abstract Traumatic brain injury in elderly patients is a
neglected global disease burden. The main cause is fall,
followed by motor vehicle accidents. This review article
summarizes different aspects of geriatric traumatic brain
injury, including epidemiology, pathology, and effects of
comorbidities and pre-injury medications such as antiplate-
lets and anticoagulants. Functional outcome with or without
surgical intervention, cognitive outcome, and psychiatric
complications are discussed. Animal models are also
reviewed in attempt to explain the relationship of aging
and outcome, together with advances in stem cell research.
Though elderly people in general did fare worse after traumatic
brain injury, certain “younger elderly” people, aged 65–
75 years, could have a comparable outcome to younger adults
after minor to moderate head injury.
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Introduction
According to the World Health Organization, traumatic
brain injury (TBI) will lead as the major cause of death
and disability by the year 2020. It is estimated that 10
million people are affected annually by TBI [1]. Often
neglected, elderly TBI patients are going to be an increas-
ing burden to the society with the worldwide aging popu-
lation. Peschman et al. [2] showed that age alone is
associated with increased odds of being admitted to the
hospital after head injury.
In the United States, there are 1.4 million cases of TBI
per year, causing over 90,000 cases of permanent disability
and 50,000 deaths. Specifically, among the elderly, there are
155,000 cases of TBI annually in the United States leading
to 12,000 deaths [3]. There is also an increasing incidence of
patients with TBI being discharged to the elderly home over
the recent years [4].
Elderly patients suffering from head injury were tradi-
tionally thought to have an inferior outcome. They were
more likely to go to inpatient rehabilitation or long-term
care facilities, or died compared to young and middle-aged
patients [5]. Elderly TBI patients also bear higher cost
during hospital stay in cost-analysis models [6].
Thus, elderly TBI patients tend to be treated less aggres-
sively. In a retrospective multicenter study in Scotland, older
patients with acute intracranial hematomas were less likely
to be transferred for specialist neurosurgical care than
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younger patients with similar severities of injuries, extracra-
nial injuries, and physiological status at presentation, irre-
spective of associated medical morbidities [7].
These concepts are recently being challenged as clini-
cians observe that with adequate resources, timely and
appropriate surgical intervention, neurointensive care,
and aggressive neurorehabilitation, both functional and
cognitive outcome of elderly TBI patients may be as
good as the younger counterparts. We thus reviewed the
current evidence in the literature regarding factors affecting
outcome after geriatric TBI and aimed to define the role of
aggressive neurosurgical management in geriatric TBI.
Methods
Studies included in the present article were identified by
searching through PubMed and MEDLINE using keywords:
[traumatic brain injury OR head injury] AND [elderly OR
geriatric] AND [epidemiology OR outcome]. Non-English
articles were excluded.
Epidemiology
Trauma literature usually defines “elderly” as more than
65 years of age, which is used in this review unless otherwise
specified [6, 7, 8••, 9•, 10, 11••, 12–14, 15••, 16–24].
Incidence of elderly TBI has doubled in the past 18 years
that the increase in elderly TBI is greatest for individuals
aged 83–90 years [15••]. Fall at level ground is the leading
cause of TBI in elderly patients, followed by motor vehicle
accidents (MVA) [5, 19, 25–27]. It may be postulated that
the increase in elderly TBI can be explained by an increase
in life expectancy and advances in health care; while
physiologically, elderly people are more susceptible to fall.
Fall is a major disease burden worldwide. In a retrospective
cohort in India, 40 % of the elderly patients who fell injured
their heads, where half of them presented with severe head
injury (Glasgow Coma Scale [GCS]<9) [28]. In the United
States (Oklahoma), the rate of elderly fall causing TBI showed
120 % increase over the last decade [18].
Hong Kong, one of the busiest cities in Asia, has a low
MVA-related death rate (2.4 per 100,000), which is 25 % of
Australian and 15 % of U.S. rates. In Hong Kong, 37 % of
MVA-related death was among elderly people over 60 years
old. Over 80 % of the deceased across all age groups
sustained head injury [29].
Pathology
Acute subdural hematoma was the commonest pathology
for elderly TBI [30], which corresponds with a coroner’s
report that subdural hematoma was the commonest lesion of
the deceased elderly persons with head injuries [12].
Comorbidities
Medical comorbidities are found in 40 % of the elderly
population [31]. They are more likely to suffer from cardio-
vascular diseases, and may lead to the overwhelming
prescription of anticoagulation and antiplatelet agents,
which are discussed in details below.
Anticoagulants
Almost one fifth of elderly patients older than 65 years old
admitted to an American level 1 trauma center with head
injury were on warfarin, reflecting the importance of impact
of warfarin onmanagement and outcome of head injuries [14].
Warfarin consumption is independently associated with
higher mortality among a cohort of 384 TBI patients over
55 years old [32]. Those on warfarin with minor head
injuries (GCS≥13) are 2.7 times more likely to suffer from
intracranial hemorrhage (ICH), and traumatic ICH was
associated with supratherapeutic international normalized
ratio (INR) [33].
In a retrospective analysis of 1493 patients with head
injury, INR over 4.0 and age over 70 years were associated
with higher mortality. Warfarin carries a sixfold increase in
TBI mortality [34]. Pieracci et al. [14] compared warfarin
users with mean INR 3.3 versus those with suboptimal level,
with the former group having a lower GCS score on presen-
tation and higher mortality after head injury. Karni et al. [35]
reported similarly that the 30-day mortality was 50 % in
warfarinized elderly patients with mean INR 3.0, compared
to the mortality of 20 % in nonwarfarinized counterparts.
With a mean initial INR of 4.0, warfarin can be even more
lethal in elderly TBI, with over 80 % mortality in those with
initial minor head injury [36].
Delayed ICH with oral anticoagulant and head injury also
were reported among elderly patients [37]. However, routine
follow scan in negative first computer tomography (CT)
scan of brain in warfarinized patients has a very low yield
of 1 % delayed ICH after head injury [22, 38].
New direct coagulation factor inhibitors, such as
dabigatran, have suggested superior stroke and systemic
embolism prevention with less drug–drug interactions.
However, there is still no specific reversal agent and
routine laboratory essay to measure anticoagulation level
in patients with traumatic ICH [39].
Antiplatelets
Pre-injury antiplatelet agents were associated with three
times higher mortality among patients over 50 years old,
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where it was due to a functional rather than quantitative
deficiency of platelets [26].
Intracranial bleeding progressed in 10 % of elderly TBI
patients on clopidogrel. They were three times more likely
to be discharged to long-term inpatient facilities and 14
times higher mortality rate as compared with those not on
antiplatelets [40].
However, platelet transfusion was shown not beneficial
in terms of mortality among patients older than 50 years old
with pre-injury antiplatelets who suffered from TBI with
ICH [41]. Routine platelet transfusion may even be harmful.
Washington et al. [42••] showed that in patients who were
on antiplatelets and sustained minor head injury, where the
first CT scan showed intracranial hematoma that did not
require immediate operative treatment, platelet transfusion
had a higher rate of medical complications, including death
due to cardiac causes. There was no difference in terms of
neurological decline between the transfused and nontrans-
fused group. Fortuna et al. [43] similarly reported higher
mortality for patients with pre-injury antiplatelets who re-
ceived platelet transfusion therapy compared with those
who were not transfused. Utilization of commercially avail-
able aspirin response test could assess the effect of existing
aspirin therapy in TBI patients, thus possibly avoiding un-
necessary futile platelet transfusion [44].
β-Blockers
The relationship with use of β-blockers and outcome in TBI
patients is complex. On one hand, some retrospective data
suggest that β-blocker users have a lower mortality in
elderly patients suffering from severe blunt head injury,
hypothesizing that β-blockade may result in attenuation of
intracerebral post-traumatic catecholamine-induced vaso-
spasm, decreasing potential for local ischemia [45]. How-
ever, in those with severe systemic injuries, β-blockers may
mask the systemic response to trauma, leading to higher
mortality [21].
Statins
Preinjury statin use in elderly TBI patients is associated
with reduced risk of death and greater likelihood of achiev-
ing a good recovery at 12 months postinjury, possibly
related to anti-inflammatory and immunomodulatory
effects of statins [23].
Functional Outcome
The overall mortality for elderly TBI patients older than
65 years old was 14 %–55 % [11••, 17–19, 24, 25, 46],
and was affected mainly by GCS on admission, followed
by age.
GCS on admission, described by Jennett et al. in 1976
[47], had long been known to predict outcome. In a large
multicenter epidemiologic study of TBI in China, minor
head injury patients (GCS 13–15) had over 90 % survival,
where less than 20 % achieved good outcome in severe head
injury patients (GCS 3–8) [46]. Several studies also showed
severe head injury among elderly led to high mortality,
ranging from 68 %–92.5 %, and less than one fifth achieved
good outcome at 6 months (Table 1).
Despite the fact that older patients tend to suffer from less
severe injuries, elderly age is associated with higher mortality
and worse functional status at discharge [3, 15••, 24, 25, 50].
Elderly patients over 70 years old sustaining severe head
injury had 80 % mortality and no one made good recovery
at 6 months. The outcome was similar in the same center over
10 year’s time. However, the sample size was small [30].
Another multicenter study in Japan reported that good
recovery was only achieved in 10 % in those victims over
50 years old, with over 60 % mortality, and 10 % remained
in vegetative state. The factor of neurosurgical intervention
was not included [51].
Recent large-scale studies suggested that the outcome of
elderly TBI is encouraging. Elderly patients over 65 years
old had a survival rate of over 80 % at a retrospective cohort
data at a level II trauma center in Florida from 2005 to 2008
[11••]. In a large-scale multicenter epidemiologic study of
TBI in Eastern China conducted in 2004, around 60 % of
TBI patients over 65 years old enjoyed good recovery [46].
Increasing number of elderly individuals are surviving
moderate to severe TBI over the past two decades as
reported by Ramanathan et al. [15], similar to findings using
statewide data collected in Oklahoma [18]. When adjusted
for sex, year of TBI, and TBI severity, elderly patients
showed similar risk of death following head injury as younger
patients [17]. In a 10-year Singapore review, though signifi-
cantly less than the younger victims, 36 % of elderly with
initial GCS over 8 managed to attain good outcome [19].
Inpatient rehabilitation was shown to improve outcome at
6 months even in certain deeply comatose elderly head
injury patients, as measured by significant gains on the
modified Barthel Index after rehabilitation [52].
“Younger” Elderly
Neurosurgical unit care, especially in intensive care unit,
significantly reduced mortality in those with severe head
injury between 65 and 70 years old. Mortality in severe
TBI elderly with GCS 6–8 was 47 % and 56 % in patients
of 65–70 years old and 70–75 years old respectively, which
is much better than the overall mortality of 78.5 % in the
overall elderly group [8••].
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This is similar with the data from the Greek group [16],
that there is a trend of improved survival of the “younger
elderly” (65–75 years old) with ICU treatment. Furthermore,
the “younger elderly” had a comparable survival with the
younger counterparts who are less than 65 years old after
surgical intervention in patients with GCS of 8 or higher.
Surgical Intervention
Overall survival and good recovery following craniotomy in
elderly head injury was 30 %–77 %, with GCS over 8 upon
admission showing better outcome [7, 20, 31, 53••, 54].
Volume of traumatic ICH greater than 50 ml was associated
with poor 1-year outcome [25]. A cohort showed that, with
appropriate postoperative medical attention, selected
patients older than 80 years old with single traumatic hema-
toma undergoing craniotomy can similarly return to preinjury
functional conditions as their younger counterparts [55•].
On the other hand, decompressive craniectomy does not
show significant benefit in older patients after failing max-
imal medical treatment [10]. At 1 year after decompressive
craniectomy, 80 % of elderly patients with severe TBI had
poor outcome. Most patients who died had a controlled
intracranial pressure (ICP) after surgery and no surgery-
related complications. The brain’s greater exposure to minor
repetitive insults as age increases, together with the presence
of systemic comorbidities such as vasculopathies and
neuropathies, likely contributes to the brain’s reduced
capacity for recovery and may therefore have an inferior
impact on prognosis [9•].
Cognitive Outcome
There is some evidence to suggest that moderate to severe
head injury can predispose to development of cognitive
decline and even Alzheimer’s disease decades afterwards
[56–58]. A 9-year population-based study of elderly patients
also showed fall-related TBI predicts earlier onset of
dementia and the effect is especially high amongst
patients who carry the apolipoprotein E ε4 allele [59].
However, it is not reproducible in other studies, and
failed to find an association between history of TBI
and dementia [60]. Elderly patients are also more prone
to cognitive dysfunction after TBI [61].
Repetitive minor blunt head injuries can cause chronic
traumatic encephalopathy at a later stage of life, character-
ized with memory disturbances, behavioral and personality
changes, Parkinsonism, and speech and gait abnormalities.
Pathologically, there are extensive tau-immunoreactive neu-
rofibrillary tangles throughout the brain in relative absence
of β-amyloid deposits. There are reports that repetitive head
trauma also can be associated with development of motor
neuron disease [62, 63].
According to a systemic review, prevalence of depression
in community-residing elderly adults ranges from 1.8 %–
8.9 % in the community and 10 %–25 % in medical and
long-term care settings. In the general population with TBI,
prevalence rates of depression range from 10 %–42 %, with
older age being a significant factor [13, 64]. Imaging study
based on magnetic resonance imaging (MRI) suggested the
possible role of frontotemporal lobe and basal ganglia
pathology in depression after TBI [65]. TBI may increase the
risk of disinhibition in elderly patients with dementia [66].
Animal and Experimental Studies
Researchers have been trying to determine why and how age
plays a role in outcome of TBI. Onyszchuk and colleagues
[67, 68] studied the effect of trauma to the brain among
mice. Aged mice performed worse in general compared with
the adult group. The aged group showed slower resolution
in brain edema in MRI. Immunostaining showed greater
Table 1 Outcome of
elderly traumatic brain
injury with severe head

















Kilaru et al. [48] 1996 1990–1995 65+ 40 68 7.5
Hukkloven et al. [49] 2003 1991–1995 65+ 101 72 15
Ushewokunze et al. [30] 2004 1990–2000 70+ 71 80 1
Gan et al. [19] 2004 1999–2001 64+ 36 72.2 16.7





Bouras et al. [16] 2007 1998–2005 65–74 48 79.2
75+ 67 92.5
174 Curr Tran Geriatr Gerontol Rep (2012) 1:171–178
degree in opening in blood–brain barriers and higher degree
in neurodegeneration in aged mice. The effects not only
affected the acute phase, but also were present 2 months
after injury. A similar study comparing both the aged and
younger mice was published by Sandhir et al. [69], who
focused on the age-dependent response of CCAAT/enhancer
binding proteins (CEBP). The aged brain showed a significant
increase in both the CEBP β- and δ- protein, which are
responsible for glia activation in neurotoxic events and
development of Alzheimer's disease.
There have been recent advances in genetic studies related
to TBI. Colak et al. [70] identified that several genes were
upregulated in injured brains (eg, C1ql2, Cbnl, 5 dc1 Bdnf,
MMP9, and Cd47), which are responsible for neuroprotection
and nerve repair. Mehan et al. [71] showed that a series of
protein isoforms was induced only in juvenile brains but not in
the elder brains among mice.
Targeted therapies toward these particular genes have
been studied, and age also serves as an important factor in
the response of the brain toward the treatment modalities.
Nicotinamide was found to be only effective in younger
mice to improve functional recovery in TBI [72]. Nogo-A/
B, myelin-derived inhibitors to axonal outgrowth, were
genetically modified to be negative in experimental mice.
The younger mice expectedly had a better outcome, yet
showed contrary results in the aged group [73].
Preclinical trials focused on stem cell therapy to traumat-
ic nervous tissue injury are promising, as summarized by
Harting and colleagues [74]. Embryonic stem cells (ESCs)
derived from the inner mass of blastocyst are capable of
producing all tissues of the body [75]. Neural stem cells
(NSCs) isolated from subventricular zone and dentate gyrus
of hippocampus are multipotent cells with the potential to
differentiate into neurons, oligodendrocytes, and astrocytes
[76]. Clinical applications of ESCs and NSCs are hindered
by ethical controversies, concern of tumor formation, and
limited availability respectively. Mesenchymal stem cells
(MSCs) can be isolated from bone marrow and adipose
tissue, among other sources, and rapidly expanded in vitro
without losing their general multipotentiality [77]. MSCs
also can differentiate into specific cell lineages under appro-
priate microenvironment. The brain itself has a limited ca-
pacity for self-repair. Preclinical studies have demonstrated
that MSCs can facilitate the replacement of injured or non-
functioning cells and improve the functional recovery after
TBI [78–80], although the underlying mechanism remains
to be defined. Apart from engraftment and transdifferentia-
tion into neurons and astrocytes or fusion with the host cells,
MSCs may stimulate neurogenesis, gliagenesis, and synap-
togensis via secretion of neuroprotective/trophic factors as
well as modulation of microenvironment inflammatory and
systemic immunologic responses [81, 82]. TBI elicits a
cascade of pathophysiologic processes leading to neuronal
damage. Conventional pharmacologic agents usually target
only a single pathway, whereas stem cell–based therapies
can execute multiple mechanisms and thus give rise to the
hope that MSCs may be able to reverse cellular/subcellular
cascade underlying brain damage following TBI. Intrave-
nous and intra-arterial injections are most commonly routes
for the administration of MSCs in clinical trials. To date, no
adverse clinical complication caused by infusion of expand-
ed autologous MSCs for neurological diseases has been
reported [83, 84]. However, few infused MSCs reach the
injured lesion of the brain because of the pulmonary first-
pass effect [85]. The average diameter of MSCs is smaller
than that of pulmonary artery. A recent study demonstrated
that topically applied MSCs can migrate to the injured
parenchymal tissue in the models of TBI (Fig. 1) [86], and
ischemia-reperfusion injury in other somatic organs [87•].
Topical application can offer a direct delivery of millions of
MSCs to the brain. Clinical efficacy and feasibility of cell-
based therapies for TBI require further investigation in
Fig. 1 Topical application of mesenchymal stem cells (MSCs) as
potential treatment following severe traumatic brain injury (TBI)
in rats. MSCs derived from transgenic Sprague-Dawley (SD) rat
with green fluorescent protein (GFP) and a thin layer of fibrin
were topically applied on the surface of brain with TBI. a
Immunochemistry staining using anti-GFP (IHC x 100; brown)
showed the migration of GFP-MSCs (arrows) into parenchymal
brain tissue 3 days after topical MSC application. b H & E
counter-staining (x 100). IHC immunohistochemical staining; H
& E hematoxylin and eosin
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regard to cell types, cell dosage, routes of administration,
and transplantation window.
Conclusions
Elderly TBI has been and will be an important burden to the
society with longer life expectancy and an aging population,
with fall being the commonest cause. Increasing use of
antiplatelet and anticoagulation medication is going to
further complicate the condition. Outcome following
TBI in “younger elderly” (ie, those less than 75 years
old) can be comparable with younger adults with acceptable
outcome. With good case selection of minor to moderate head
injury in those relatively younger elderly victims, surgical
treatment should not be withheld, and traumatic hematoma
evacuation may be beneficial among elderly as opposed to
traditional thoughts. Current literature lack dedicated
studies to this particular group of patients with less severe
head injuries. Animal and laboratory studies showed
promising explanation of underlying mechanisms of elderly
TBI and development of novel treatment.
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